JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marc Ruel
Fraser D. Rubens
Roy G. Masters
Thierry G. Mesana
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruel, M.
Right arrow Articles by Mesana, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruel, M.
Right arrow Articles by Mesana, T. G.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2004;128:278-283
© 2004 The American Association for Thoracic Surgery


Surgery for acquired cardiovascular disease

Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves

Marc Ruel, MD, MPHa,b,*, Fraser D. Rubens, MD, MSca, Roy G. Masters, MDa, Andrew L. Pipe, MDa, Pierre Bédard, MDa, Thierry G. Mesana, MD, PhDa

a Division of Cardiac Surgery, Ottawa, Ontario, Canada
b Department of Epidemiology, University of Ottawa, Ottawa, Ontario, Canada

Received for publication September 3, 2003; revisions received November 5, 2003; accepted for publication November 10, 2003.

* Address for reprints: Marc Ruel, MD, MPH, University of Ottawa Heart Institute, 40 Ruskin Street, Suite 3403, Ottawa, Ontario, Canada K1Y 4W7
mruel{at}ottawaheart.ca

OBJECTIVE: The study's objective was to examine factors associated with persistent or recurrent congestive heart failure after mitral valve replacement.

METHODS: Patients who underwent mitral valve replacement with contemporary prostheses (N = 708) were followed with annual clinical assessment and echocardiography. Cox proportional hazard models were developed to evaluate the impact of demographic, comorbid, and valve-related variables on the occurrence of congestive heart failure after mitral valve replacement, defined as the composite outcome of New York Heart Association class III or IV symptoms or death caused by congestive heart failure postoperatively. Factors associated with all-cause mortality were also examined. Models were bootstrapped 1000 times.

RESULTS: The total follow-up was 3376 patient-years (mean 4.8 ± 3.7 years, range 60 days to 17.1 years). Freedom from New York Heart Association III or IV symptoms or death caused by congestive heart failure was 96.1% ± 0.8%, 82.7% ± 1.7%, 66.4% ± 3.0%, and 38.8% ± 6.9% at 1, 5, 10, and 15 years, respectively. Preoperative New York Heart Association class, left ventricular grade, atrial fibrillation, coronary artery disease, smoking, persistent tricuspid regurgitation, and redo status predicted congestive heart failure postoperatively (all P < .05). Patients who underwent mitral valve replacement for pure mitral stenosis had less congestive heart failure events after surgery than those with regurgitation or mixed disease. Prosthesis size and elevated transprosthesis gradients were not predictive of freedom from congestive heart failure after mitral valve replacement. Atrial fibrillation, persistent tricuspid regurgitation, and surgical referral for mitral valve replacement at an advanced functional stage were also risk factors for all-cause mortality.

CONCLUSIONS: This study identifies the incidence of and risk factors for congestive heart failure and death late after mitral valve replacement. Although prosthesis size has no effect, other potentially modifiable factors such as atrial fibrillation, persistent tricuspid regurgitation, and late surgical referral have a negative impact on freedom from congestive heart failure and overall survival after mitral valve replacement.





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Totaro and V. Argano
Reply to the Editor.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 465 - 466.
[Full Text] [PDF]


Home page
CirculationHome page
M. Ruel, V. Chan, P. Bedard, A. Kulik, L. Ressler, B. K. Lam, F. D. Rubens, W. Goldstein, P. J. Hendry, R. G. Masters, et al.
Very Long-Term Survival Implications of Heart Valve Replacement With Tissue Versus Mechanical Prostheses in Adults <60 Years of Age
Circulation, September 11, 2007; 116(11_suppl): I-294 - I-300.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Totaro and V. Argano
Patient prosthesis mismatch after mitral valve replacement: Myth or reality?
J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 697 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B.-K. Lam, V. Chan, P. Hendry, M. Ruel, R. Masters, P. Bedard, B. Goldstein, F. Rubens, and T. Mesana
The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1464 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Mirabel, B. Iung, G. Baron, D. Messika-Zeitoun, D. Detaint, J.-L. Vanoverschelde, E. G. Butchart, P. Ravaud, and A. Vahanian
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?
Eur. Heart J., June 1, 2007; 28(11): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. M. Bolman III
Survival After Mitral Valve Replacement: Does the Valve Type and/or Size Make a Difference?
Circulation, March 20, 2007; 115(11): 1336 - 1338.
[Full Text] [PDF]


Home page
CirculationHome page
J. Magne, P. Mathieu, J. G. Dumesnil, D. Tanne, F. Dagenais, D. Doyle, and P. Pibarot
Impact of Prosthesis-Patient Mismatch on Survival After Mitral Valve Replacement
Circulation, March 20, 2007; 115(11): 1417 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. L. Ngaage, H. V. Schaff, S. A. Barnes, T. M. Sundt III, C. J. Mullany, J. A. Dearani, R. C. Daly, and T. A. Orszulak
Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?
Ann. Thorac. Surg., October 1, 2006; 82(4): 1392 - 1399.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Fukuda, A. M. Gillinov, P. M. McCarthy, W. J. Stewart, J.-M. Song, T. Kihara, M. Daimon, M.-S. Shin, J. D. Thomas, and T. Shiota
Determinants of Recurrent or Residual Functional Tricuspid Regurgitation After Tricuspid Annuloplasty
Circulation, July 4, 2006; 114(1_suppl): I-582 - I-587.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. B. Vanky, E. Hakanson, E. Tamas, and R. Svedjeholm
Risk Factors for Postoperative Heart Failure in Patients Operated on for Aortic Stenosis
Ann. Thorac. Surg., April 1, 2006; 81(4): 1297 - 1304.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.